Agilent Technologies (NYSE:A) PT Raised to $92.00

Agilent Technologies (NYSE:A) had its target price raised by Needham & Company LLC to $92.00 in a research note issued to investors on Monday, The Fly reports. Needham & Company LLC currently has a buy rating on the medical research company’s stock.

A number of other brokerages have also recently commented on A. Deutsche Bank reduced their price objective on Agilent Technologies from $90.00 to $85.00 and set a buy rating on the stock in a research note on Wednesday, May 15th. Barclays cut Agilent Technologies from an overweight rating to an equal weight rating and reduced their price objective for the stock from $86.00 to $78.00 in a research note on Monday, July 15th. Zacks Investment Research cut Agilent Technologies from a buy rating to a hold rating and set a $75.00 price objective on the stock. in a research note on Monday. Bank of America cut Agilent Technologies from a buy rating to a neutral rating and set a $76.00 price objective on the stock. in a research note on Tuesday, July 16th. Finally, ValuEngine cut Agilent Technologies from a buy rating to a hold rating in a research note on Friday, July 12th. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $84.77.

Shares of A opened at $71.74 on Monday. The stock’s 50-day moving average is $70.35 and its two-hundred day moving average is $74.50. The stock has a market cap of $22.67 billion, a PE ratio of 25.71, a P/E/G ratio of 1.98 and a beta of 1.41. Agilent Technologies has a 12 month low of $61.01 and a 12 month high of $82.27. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.13 and a quick ratio of 1.72.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 14th. The medical research company reported $0.76 EPS for the quarter, topping the Zacks’ consensus estimate of $0.72 by $0.04. The company had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The firm’s quarterly revenue was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.67 earnings per share. On average, research analysts anticipate that Agilent Technologies will post 3.08 earnings per share for the current year.

Several large investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its position in shares of Agilent Technologies by 4.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,031,349 shares of the medical research company’s stock valued at $69,567,000 after acquiring an additional 47,062 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Agilent Technologies by 7.2% during the 4th quarter. Geode Capital Management LLC now owns 4,234,035 shares of the medical research company’s stock valued at $285,139,000 after acquiring an additional 285,330 shares during the last quarter. Virtu Financial LLC bought a new position in shares of Agilent Technologies during the 1st quarter valued at approximately $319,000. Strs Ohio boosted its position in shares of Agilent Technologies by 30.2% during the 1st quarter. Strs Ohio now owns 21,295 shares of the medical research company’s stock valued at $1,711,000 after acquiring an additional 4,934 shares during the last quarter. Finally, Financial Gravity Wealth Inc. bought a new position in shares of Agilent Technologies during the 1st quarter valued at approximately $52,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Oversold

The Fly

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.